PALB2 and breast cancer: Two recent reports have shown that PALB2 protein truncating variants are associated with a significantly increased risk of breast cancer (BC relative risk 3.83 and 5.02, respectively) and accounts for 9.5–10.1% of the protein truncating variants of the eight core BC genes mentioned above (0.39–0.56% of all BC cases) [4,5].